Control | CAO-1 | CAO-2 | CAR | |
---|---|---|---|---|
Nonischemic region | ||||
Endomyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.73 ± 0.05 | 0.77 ± 0.08 | 0.98 ± 0.10 | 0.98 ± 0.14 |
GHRP-6 (n = 8) | 1.06 ± 0.11 | 0.89 ± 0.07 | 1.10 ± 0.12 | 1.05 ± 0.13 |
GH (n = 4) | 0.90 ± 0.10 | 0.91 ± 0.04 | 1.18 ± 0.09 | 1.04 ± 0.09 |
Midmyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.59 ± 0.04 | 0.65 ± 0.07 | 0.85 ± 0.08 | 0.84 ± 0.13 |
GHRP-6 (n = 8) | 0.91 ± 0.11 | 0.78 ± 0.07 | 0.96 ± 0.09 | 0.97 ± 0.12 |
GH (n = 4) | 0.78 ± 0.10 | 0.79 ± 0.07 | 1.09 ± 0.09 | 0.97 ± 0.03 |
Epimyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.51 ± 0.02 | 0.60 ± 0.07 | 0.78 ± 0.10 | 0.72 ± 0.12 |
GHRP-6 (n = 8) | 0.69 ± 0.07 | 0.65 ± 0.04 | 0.80 ± 0.05 | 0.79 ± 0.08 |
GH (n = 4) | 0.61 ± 0.04 | 0.68 ± 0.05 | 0.94 ± 0.08 | 0.75 ± 0.03 |
Ischemic region | ||||
Endomyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.67 ± 0.04 | 0.04 ± 0.01* | 0.08 ± 0.01* | 1.76 ± 0.15* |
GHRP-6 (n = 8) | 0.97 ± 0.11 | 0.05 ± 0.01* | 0.05 ± 0.01* | 1.18 ± 0.18 |
GH (n = 4) | 0.80 ± 0.06 | 0.06 ± 0.01* | 0.06 ± 0.01* | 1.96 ± 0.46 |
Midmyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.63 ± 0.03 | 0.07 ± 0.02* | 0.17 ± 0.04* | 1.94 ± 0.24* |
GHRP-6 (n = 8) | 0.84 ± 0.10 | 0.08 ± 0.01* | 0.11 ± 0.01* | 1.56 ± 0.17* |
GH (n = 4) | 0.72 ± 0.04 | 0.06 ± 0.01* | 0.10 ± 0.01* | 1.53 ± 0.24 |
Epimyocardial (ml/min/g) | ||||
Vehicle (n = 6) | 0.50 ± 0.01 | 0.12 ± 0.04* | 0.27 ± 0.08* | 1.01 ± 0.15* |
GHRP-6 (n = 8) | 0.65 ± 0.05 | 0.12 ± 0.02* | 0.20 ± 0.03* | 1.34 ± 0.21* |
GH (n = 4) | 0.56 ± 0.07 | 0.11 ± 0.02* | 0.17 ± 0.05* | 1.06 ± 0.40 |
↵* p < 0.05 vs. control.